|
Thymosin β4 (16-38)
|
|
|
|
|
TNF-α (10-36) (human)
|
|
|
|
|
TNF-α (31-45) (human)
|
|
|
|
|
TNF-α (46-65) (human)
|
|
|
|
|
TNF-α (78-96) (human)
|
|
|
|
|
Transforming Growth Factor α (human) (TGF α (1-50) (human))
|
|
|
|
|
Tyr-[Hu-rasT24]-Lys
|
|
|
|
|
Tyr-PDGF A-Chain (194-211)
|
|
|
|
|
Urechistachykinin I
|
|
|
|
|
Urechistachykinin II
|
|
|
|
|
Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2 (Met-Enkephalin-Arg-Phe-amide)
|
|
|
|
|
Uremic Pentapeptide (U5-Peptide)
|
|
|
|
|
Urinary Trypsin Inhibitor Fragment
|
|
|
|
|
Urocortin (human)
|
|
|
|
|
Urocortin (rat)
|
|
|
|
|
Urocortin (rat) (free acid)
|
|
|
|
|
Urotensin II
|
|
|
|
|
Vasonatrin Peptide (VNP)
|
|
|
|
|
VIP (1-12) (human, porcine, rat)
|
|
|
|
|
VIP (6-28) (human, bovine, porcine, rat)
|
|
|
|
|
VIP (human, bovine, porcine, rat)
|
|
|
|
|
VIP Antagonist
|
|
|
|
|
VIP (10-28) (human, bovine, porcine, rat)
|
|
|
|
|
Valosin (porcine) (Peptide VQY (porcine))
|
|
|
|
|
Valorphin
|
|
|
|
|
Urotensin I
|
|
|
|
|
VIP Antagonist ([Ac-Tyr1, D-Phe2l-Growth Hormone Releasing Factor amide (1-29) (human)) (VIP antagonist)
|
|
|
|
|
VIP Receptor Binding Inhibitor
|
|
|
|
|
Xenopsin-Related Peptide 1 (XP-1)
|
|
|
|
|
α Bag Cell Peptide (1-9)
|
|
|
|
|
α-CAS:ein (90-95)
|
|
|
|
|
α-CGRP (8-37) (rat)
|
|
|
|
|
α-Conotoxin EI
|
|
|
|
|
α-Conotoxin MI
|
|
|
|
|
α-Conotoxin SI
|
|
|
|
|
α-Endorphin (β-Lipotropin (61-76), β-Endorphin (1-16))
|
|
|
|
